Respiratory failure & ventilation

Interpretation of results of PCR and B-D-glucan for the diagnosis of Pneumocystis Jirovecii Pneumonia in immunocompromised adults with acute respiratory failure

Ann Intensive CarePublished Diagnostic accuracy study

Authors' conclusion

Although both tests yield a high intrinsic performance, the low incidence of PJP in this cohort resulted in a low positive post-test probability.

Study context

Population
Non-HIV immunocompromised adults with acute respiratory failure
Participants
2,243 participants
Comparison
PCR vs Beta-D-Glucan (BDG) for diagnosis of PJP
Outcome
Post-test probability of PJP according to PCR and BDG results
Methodological detailsBayesian post-test probability simulation, diagnostic performance extracted from literature
  • Bayesian post-test probability simulation
  • Diagnostic performance extracted from literature

Performance

As reported in the abstract

Post-test probability of PJP, overall population
Test or modelPositive post-test probabilityNegative post-test probability
PCR32.9% (95%CI 31.1-34.8)0.10% (95%CI 0.09-0.11)
BDG22.8% (95%CI 21.5-24.3)0.23% (95%CI 0.21-0.25)

Positive post-test probability

PCR32.9% (95%CI 31.1-34.8)
BDG22.8% (95%CI 21.5-24.3)

Negative post-test probability

PCR0.10% (95%CI 0.09-0.11)
BDG0.23% (95%CI 0.21-0.25)
Incidence of PJP in non-HIV acute respiratory failure (ARF) patients
4.1% (95%CI 3.3-5)

Further findings

OutcomePCRBDG
PPV in highest risk subgroup
PPV74.5% (95%CI 72.0-76.7)63.8% (95%CI 60.8-65.8)

Incidence of PJP in 4 subgroups (supervised classification)

Lowest: no ground glass opacities
2.0% (95%CI 1.4-2.8)
Highest: hematopoietic cell transplantation, ground glass opacities and no PJP prophylaxis
20.2% (95%CI 14.1-27.7)

Original publication

Interpretation of results of PCR and B-D-glucan for the diagnosis of Pneumocystis Jirovecii Pneumonia in immunocompromised adults with acute respiratory failure. Ann Intensive Care. Published 31 July 2024. doi:10.1186/s13613-024-01337-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.